Clinical Trial Update: Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS) [Phase 2]

View source ↗

Summary

A Phase 2 trial (BLESS) is investigating neoadjuvant PD-1 blockade in elderly patients with esophageal squamous cell carcinoma. The study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• PD-1 blockade

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: RECRUITING